Disclosure Of Interests In Other Entities [Text Block]

Pharming Group N.V. - Filing #2154299

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
316,342,000 USD
277,500,000 USD
Non-current assets
146,512,000 USD
148,297,000 USD
Current liabilities
77,968,000 USD
59,698,000 USD
Non-current liabilities
166,105,000 USD
161,461,000 USD
Revenue
245,316,000 USD
205,622,000 USD
Profit (loss)
USD
10,548,000 USD
10,548,000 USD
USD
USD
USD
USD
13,674,000 USD
USD
13,674,000 USD
Comprehensive income
USD
3,445,000 USD
10,548,000 USD
USD
7,103,000 USD
USD
11,054,000 USD
2,620,000 USD
USD
13,674,000 USD
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
USD
7,103,000 USD
USD
USD
7,103,000 USD
USD
11,054,000 USD
11,054,000 USD
USD
USD
Investments accounted for using equity method
2,285,000 USD
2,501,000 USD
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
61,741,000 USD
207,342,000 USD
191,924,000 USD
Tax expense (income)
1,464,000 USD
1,313,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.